April 2016

Chairman’s Letter
Chairman's Letter
Michael J. Hennessy
From the Editor
From the Editor
Debu Tripathy, MD
Advanced NSCLC
Personalizing Therapy for Acquired Resistance to EGFR Kinase Inhibitors in Advanced NSCLC
Adrian G. Sacher, MD; Geoffrey R. Oxnard, MD
Breast Cancer Staging
Utility and Costs of Routine Staging Scans in Early Stage Breast Cancer | PER
Samuel A. Merrill, MD, PhD; Pamela Stevens, RN; Claire Verschraegen, MD; Marie E. Wood, MD
Melanoma Therapy
An Update on Talimogene Laherparepvec
Matthew P. Doepker, MD; Jonathan S. Zager, MD, FACS
Contralateral Mastectomy
Contralateral Prophylactic Mastectomy: Pros and Cons
Anees B. Chagpar, MD, MSc, MPH, MA, MBA
CME/CE: Immuotherapies in Cancer
Adverse Events with Targeted Therapies and Immunotherapies